const {
  Document, Packer, Paragraph, TextRun, Table, TableRow, TableCell,
  AlignmentType, HeadingLevel, BorderStyle, WidthType, ShadingType,
  VerticalAlign, PageNumber, Header, Footer, UnderlineType,
  LevelFormat, NumberFormat, TabStopType, TabStopPosition
} = require('docx');
const fs = require('fs');

// Helper functions
function heading1(text) {
  return new Paragraph({
    text: text,
    heading: HeadingLevel.HEADING_1,
    spacing: { before: 300, after: 150 },
  });
}

function heading2(text) {
  return new Paragraph({
    text: text,
    heading: HeadingLevel.HEADING_2,
    spacing: { before: 240, after: 120 },
  });
}

function heading3(text) {
  return new Paragraph({
    text: text,
    heading: HeadingLevel.HEADING_3,
    spacing: { before: 200, after: 80 },
  });
}

function para(text, opts = {}) {
  return new Paragraph({
    children: [new TextRun({ text: text, ...opts })],
    spacing: { before: 80, after: 80 },
    alignment: opts.alignment || AlignmentType.JUSTIFIED,
  });
}

function boldPara(text) {
  return new Paragraph({
    children: [new TextRun({ text: text, bold: true })],
    spacing: { before: 80, after: 80 },
  });
}

function bullet(text, level = 0) {
  return new Paragraph({
    children: [new TextRun({ text: text })],
    bullet: { level: level },
    spacing: { before: 40, after: 40 },
  });
}

function numberedPara(text, num) {
  return new Paragraph({
    children: [
      new TextRun({ text: `${num}. `, bold: true }),
      new TextRun({ text: text }),
    ],
    spacing: { before: 60, after: 60 },
    alignment: AlignmentType.JUSTIFIED,
  });
}

function indentedPara(text, opts = {}) {
  return new Paragraph({
    children: [new TextRun({ text: text, ...opts })],
    indent: { left: 720 },
    spacing: { before: 40, after: 40 },
    alignment: AlignmentType.JUSTIFIED,
  });
}

function markBox(marks, description) {
  return new Paragraph({
    children: [
      new TextRun({ text: `[${marks} marks] `, bold: true, color: '2E75B6' }),
      new TextRun({ text: description, italics: true }),
    ],
    spacing: { before: 40, after: 40 },
  });
}

function dividerLine() {
  return new Paragraph({
    children: [new TextRun({ text: '─'.repeat(80) })],
    spacing: { before: 120, after: 120 },
    alignment: AlignmentType.CENTER,
  });
}

function emptyLine() {
  return new Paragraph({ children: [new TextRun({ text: '' })], spacing: { before: 60, after: 60 } });
}

// Mark allocation table
function createMarkTable() {
  return new Table({
    width: { size: 100, type: WidthType.PERCENTAGE },
    borders: {
      top: { style: BorderStyle.SINGLE, size: 1 },
      bottom: { style: BorderStyle.SINGLE, size: 1 },
      left: { style: BorderStyle.SINGLE, size: 1 },
      right: { style: BorderStyle.SINGLE, size: 1 },
      insideH: { style: BorderStyle.SINGLE, size: 1 },
      insideV: { style: BorderStyle.SINGLE, size: 1 },
    },
    rows: [
      new TableRow({
        children: [
          new TableCell({
            children: [new Paragraph({ children: [new TextRun({ text: 'Section', bold: true })], alignment: AlignmentType.CENTER })],
            shading: { fill: '2E75B6', type: ShadingType.SOLID },
            verticalAlign: VerticalAlign.CENTER,
            width: { size: 40, type: WidthType.PERCENTAGE },
          }),
          new TableCell({
            children: [new Paragraph({ children: [new TextRun({ text: 'Topic', bold: true })], alignment: AlignmentType.CENTER })],
            shading: { fill: '2E75B6', type: ShadingType.SOLID },
            verticalAlign: VerticalAlign.CENTER,
            width: { size: 45, type: WidthType.PERCENTAGE },
          }),
          new TableCell({
            children: [new Paragraph({ children: [new TextRun({ text: 'Marks', bold: true })], alignment: AlignmentType.CENTER })],
            shading: { fill: '2E75B6', type: ShadingType.SOLID },
            verticalAlign: VerticalAlign.CENTER,
            width: { size: 15, type: WidthType.PERCENTAGE },
          }),
        ],
      }),
      ...([
        ['Part A', 'Definition and classification of pharmacological behaviour management techniques', '5'],
        ['Part B (i)', 'Oral and intranasal sedation agents', '5'],
        ['Part B (ii)', 'Intravenous sedation agents (benzodiazepines, propofol)', '8'],
        ['Part C (i)', 'Pharmacology and properties of nitrous oxide', '7'],
        ['Part C (ii)', 'Indications, contraindications and patient selection', '5'],
        ['Part C (iii)', 'Equipment and safety features', '6'],
        ['Part C (iv)', 'Technique of administration and planes of analgesia', '7'],
        ['Part C (v)', 'Complications, occupational hazards and scavenging', '5'],
        ['Part D', 'Critical appraisal / comparative analysis', '2'],
        ['', 'TOTAL', '50'],
      ].map((row, idx) =>
        new TableRow({
          children: [
            new TableCell({
              children: [new Paragraph({ children: [new TextRun({ text: row[0], bold: idx === 9 })], alignment: AlignmentType.CENTER })],
              shading: idx === 9 ? { fill: 'D6E4F0', type: ShadingType.SOLID } : {},
            }),
            new TableCell({
              children: [new Paragraph({ children: [new TextRun({ text: row[1], bold: idx === 9 })], alignment: AlignmentType.LEFT })],
              shading: idx === 9 ? { fill: 'D6E4F0', type: ShadingType.SOLID } : {},
            }),
            new TableCell({
              children: [new Paragraph({ children: [new TextRun({ text: row[2], bold: idx === 9 })], alignment: AlignmentType.CENTER })],
              shading: idx === 9 ? { fill: 'D6E4F0', type: ShadingType.SOLID } : {},
            }),
          ],
        })
      )),
    ],
  });
}

const doc = new Document({
  numbering: {
    config: [
      {
        reference: 'numbering',
        levels: [
          {
            level: 0,
            format: LevelFormat.DECIMAL,
            text: '%1.',
            alignment: AlignmentType.LEFT,
          },
        ],
      },
    ],
  },
  sections: [
    {
      properties: {},
      headers: {
        default: new Header({
          children: [
            new Paragraph({
              children: [
                new TextRun({ text: 'POSTGRADUATE EXAMINATIONS IN DENTISTRY', bold: true, size: 18 }),
                new TextRun({ text: '\t' }),
                new TextRun({ text: 'PREVENTIVE DENTISTRY & CONSCIOUS SEDATION', size: 18 }),
              ],
              tabStops: [{ type: TabStopType.RIGHT, position: TabStopPosition.MAX }],
              border: { bottom: { style: BorderStyle.SINGLE, size: 6, color: '2E75B6' } },
            }),
          ],
        }),
      },
      footers: {
        default: new Footer({
          children: [
            new Paragraph({
              children: [
                new TextRun({ text: 'Page ', size: 18 }),
                new TextRun({ children: [PageNumber.CURRENT], size: 18 }),
                new TextRun({ text: ' of ', size: 18 }),
                new TextRun({ children: [PageNumber.TOTAL_PAGES], size: 18 }),
                new TextRun({ text: '\t\tConfidential — For Examiners Use Only', italics: true, size: 18 }),
              ],
              tabStops: [{ type: TabStopType.RIGHT, position: TabStopPosition.MAX }],
              border: { top: { style: BorderStyle.SINGLE, size: 6, color: '2E75B6' } },
            }),
          ],
        }),
      },
      children: [
        // ==============================
        // TITLE PAGE BLOCK
        // ==============================
        new Paragraph({
          children: [new TextRun({ text: 'POSTGRADUATE EXAMINATIONS IN DENTISTRY', bold: true, size: 32, color: '2E75B6' })],
          alignment: AlignmentType.CENTER,
          spacing: { before: 400, after: 100 },
        }),
        new Paragraph({
          children: [new TextRun({ text: 'PREVENTIVE DENTISTRY', bold: true, size: 28 })],
          alignment: AlignmentType.CENTER,
          spacing: { before: 100, after: 100 },
        }),
        new Paragraph({
          children: [new TextRun({ text: 'Final Written Examination', italics: true, size: 24 })],
          alignment: AlignmentType.CENTER,
          spacing: { before: 80, after: 60 },
        }),
        new Paragraph({
          children: [new TextRun({ text: 'Paper II — Behaviour Management & Patient Sedation', size: 22 })],
          alignment: AlignmentType.CENTER,
          spacing: { before: 60, after: 300 },
        }),
        dividerLine(),
        emptyLine(),

        // ==============================
        // EXAM INSTRUCTIONS
        // ==============================
        new Paragraph({
          children: [new TextRun({ text: 'GENERAL INSTRUCTIONS', bold: true, size: 22, underline: { type: UnderlineType.SINGLE } })],
          alignment: AlignmentType.LEFT,
          spacing: { before: 100, after: 80 },
        }),
        bullet('Time Allowed: 3 Hours'),
        bullet('Maximum Marks: 50'),
        bullet('This question is compulsory and carries the full 50 marks.'),
        bullet('Answer ALL parts of the question.'),
        bullet('Marks allocated to each sub-part are shown in brackets [ ].'),
        bullet('Write legibly. Relevant diagrams / flow-charts will be awarded additional credit.'),
        bullet('Use of headings and sub-headings is strongly encouraged.'),
        emptyLine(),
        dividerLine(),
        emptyLine(),

        // ==============================
        // THE QUESTION
        // ==============================
        new Paragraph({
          children: [new TextRun({ text: 'QUESTION (50 Marks)', bold: true, size: 28, color: '2E75B6' })],
          alignment: AlignmentType.LEFT,
          spacing: { before: 200, after: 120 },
        }),

        new Paragraph({
          children: [
            new TextRun({ text: 'A 28-year-old patient presents to your postgraduate dental clinic with severe dental anxiety (Modified Corah Dental Anxiety Scale score = 15). She has avoided dental care for 6 years due to a traumatic childhood experience. Clinical examination reveals multiple carious lesions requiring restorative treatment, extraction of two grossly broken-down molars, and a need for periodontal therapy. She reports a needle phobia and has a history of mild asthma (well-controlled on a salbutamol inhaler). Vital signs: BP 128/82 mmHg, HR 88 bpm, SpO', italics: true }),
            new TextRun({ text: '2', italics: true, subScript: true }),
            new TextRun({ text: ' 98%.', italics: true }),
          ],
          border: {
            top: { style: BorderStyle.SINGLE, size: 4, color: '2E75B6' },
            bottom: { style: BorderStyle.SINGLE, size: 4, color: '2E75B6' },
            left: { style: BorderStyle.THICK, size: 12, color: '2E75B6' },
            right: { style: BorderStyle.SINGLE, size: 4, color: '2E75B6' },
          },
          shading: { fill: 'EBF4FB', type: ShadingType.SOLID },
          spacing: { before: 120, after: 120 },
          alignment: AlignmentType.JUSTIFIED,
          indent: { left: 180, right: 180 },
        }),

        emptyLine(),

        // PART A
        new Paragraph({
          children: [new TextRun({ text: 'PART A  [5 Marks]', bold: true, size: 24, color: '1F4E79' })],
          spacing: { before: 200, after: 80 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: '(a) Define pharmacological behaviour management. ' }),
            new TextRun({ text: 'Enumerate and briefly classify the pharmacological techniques available for managing dental anxiety and facilitating dental treatment. ', }),
            new TextRun({ text: 'In your answer, distinguish between premedication, conscious sedation, and general anaesthesia.', italics: true }),
          ],
          spacing: { before: 80, after: 80 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('5', 'Definition (1) + Classification with routes (2) + Distinction between techniques (2)'),
        emptyLine(),

        // PART B
        new Paragraph({
          children: [new TextRun({ text: 'PART B  [13 Marks]', bold: true, size: 24, color: '1F4E79' })],
          spacing: { before: 200, after: 80 },
        }),
        new Paragraph({
          children: [new TextRun({ text: '(b) Discuss the following pharmacological agents used in dental sedation:' })],
          spacing: { before: 80, after: 60 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: '(i) Oral and intranasal sedation', bold: true }),
            new TextRun({ text: ' — Name the specific agents used for oral premedication and oral sedation (with doses). Describe the mechanism of action of benzodiazepines via the GABA', }),
            new TextRun({ text: 'A', subScript: true }),
            new TextRun({ text: ' receptor. Discuss the advantages and limitations of oral and intranasal routes compared to intravenous sedation.  ' }),
          ],
          spacing: { before: 80, after: 40 },
          indent: { left: 360 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('5', 'Specific agents/doses (2) + GABA mechanism (1.5) + Route comparison (1.5)'),
        emptyLine(),

        new Paragraph({
          children: [
            new TextRun({ text: '(ii) Intravenous sedation agents', bold: true }),
            new TextRun({ text: ' — Compare midazolam and diazepam with regard to pharmacokinetics (T', }),
            new TextRun({ text: '½α', subScript: true }),
            new TextRun({ text: ', T', }),
            new TextRun({ text: '½β', subScript: true }),
            new TextRun({ text: ', active metabolites, potency, amnesic properties). Describe the role of flumazenil. Briefly mention propofol as an emerging alternative and state why its use is restricted in dental practice.' }),
          ],
          spacing: { before: 80, after: 40 },
          indent: { left: 360 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('8', 'Midazolam pharmacokinetics (3) + Diazepam comparison (2) + Flumazenil (2) + Propofol discussion (1)'),
        emptyLine(),

        // PART C
        new Paragraph({
          children: [new TextRun({ text: 'PART C  [30 Marks]', bold: true, size: 24, color: '1F4E79' })],
          spacing: { before: 200, after: 80 },
        }),
        new Paragraph({
          children: [new TextRun({ text: '(c) Nitrous Oxide (N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O) – Oxygen Inhalation Sedation' }),
            new TextRun({ text: ' is widely regarded as the safest form of pharmacological behaviour management in dentistry. Answer the following regarding its use:' }),
          ],
          spacing: { before: 80, after: 80 },
          alignment: AlignmentType.JUSTIFIED,
        }),

        new Paragraph({
          children: [
            new TextRun({ text: '(i) Pharmacology and Physical Properties  [7 Marks]', bold: true }),
          ],
          spacing: { before: 120, after: 60 },
          indent: { left: 360 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: 'Describe the physical and chemical properties of N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O (preparation, storage, colour coding, solubility, blood-gas partition coefficient). Explain the concept of MAC and why N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O cannot produce surgical anaesthesia at normal atmospheric pressure. Discuss its analgesic potency in relation to parenteral morphine. Explain the pharmacokinetic basis for its rapid onset and recovery, and describe the mechanism of diffusion hypoxia.' }),
          ],
          spacing: { before: 60, after: 40 },
          indent: { left: 720 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('7', 'Physical properties/storage (1.5) + MAC concept (1.5) + Analgesic potency (1) + Kinetics/diffusion hypoxia (3)'),
        emptyLine(),

        new Paragraph({
          children: [
            new TextRun({ text: '(ii) Indications, Contraindications, and Patient Selection  [5 Marks]', bold: true }),
          ],
          spacing: { before: 120, after: 60 },
          indent: { left: 360 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: 'With reference to the clinical scenario above, discuss the indications and contraindications for N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O-O', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: ' inhalation sedation. Justify its selection for this patient. Include specific mention of: dental anxiety, needle phobia, asthmatic patients, patients with haematological disorders, and medically compromised patients.' }),
          ],
          spacing: { before: 60, after: 40 },
          indent: { left: 720 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('5', 'Indications (2) + Contraindications (1.5) + Justification for this patient (1.5)'),
        emptyLine(),

        new Paragraph({
          children: [
            new TextRun({ text: '(iii) Equipment and Safety Features  [6 Marks]', bold: true }),
          ],
          spacing: { before: 120, after: 60 },
          indent: { left: 360 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: 'Describe the components of a continuous-flow inhalation sedation unit. Enumerate and explain all mandatory safety features: minimum oxygen delivery, automatic gas cut-out, pin index safety system, colour coding, fail-safe mechanisms, oxygen flush button, and scavenging. Differentiate between a free-standing portable unit and a piped central storage system.' }),
          ],
          spacing: { before: 60, after: 40 },
          indent: { left: 720 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('6', 'Equipment components (2) + Safety features enumerated and explained (3) + Free-standing vs piped system (1)'),
        emptyLine(),

        new Paragraph({
          children: [
            new TextRun({ text: '(iv) Technique of Administration and Planes of Analgesia  [7 Marks]', bold: true }),
          ],
          spacing: { before: 120, after: 60 },
          indent: { left: 360 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: 'Describe the step-by-step technique for administering N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O-O', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: ' inhalation sedation: from patient preparation, pre-operative checks, and mask placement, through titration technique (constant liter flow vs constant O', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: ' flow), to discharge criteria. Describe the three planes of analgesia (Guedel stage I) with the characteristic signs and symptoms at each plane, including N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O concentration ranges. Explain the role of hypnotic suggestion in this technique.' }),
          ],
          spacing: { before: 60, after: 40 },
          indent: { left: 720 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('7', 'Patient prep and technique steps (3) + Three planes with signs/symptoms/concentrations (3) + Role of suggestion (1)'),
        emptyLine(),

        new Paragraph({
          children: [
            new TextRun({ text: '(v) Complications, Occupational Hazards, and Pollution Control  [5 Marks]', bold: true }),
          ],
          spacing: { before: 120, after: 60 },
          indent: { left: 360 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: 'Enumerate the acute complications of N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O inhalation sedation and their management (over-sedation, nausea/vomiting, diffusion hypoxia, equipment failure). Discuss the chronic occupational hazards of N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O exposure to dental personnel (haematological, neurological, reproductive effects; methionine synthase inactivation, vitamin B', }),
            new TextRun({ text: '12', subScript: true }),
            new TextRun({ text: ' pathway). Explain measures to reduce N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O pollution including active scavenging, NIOSH exposure limits (25 ppm operating room; 50 ppm dental office), and legal requirements.' }),
          ],
          spacing: { before: 60, after: 40 },
          indent: { left: 720 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('5', 'Acute complications and management (2) + Chronic occupational hazards/mechanism (2) + Pollution control/NIOSH (1)'),
        emptyLine(),

        // PART D
        new Paragraph({
          children: [new TextRun({ text: 'PART D  [2 Marks]', bold: true, size: 24, color: '1F4E79' })],
          spacing: { before: 200, after: 80 },
        }),
        new Paragraph({
          children: [
            new TextRun({ text: '(d) ' }),
            new TextRun({ text: 'Critically compare', bold: true }),
            new TextRun({ text: ' inhalation sedation (N', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: 'O-O', }),
            new TextRun({ text: '2', subScript: true }),
            new TextRun({ text: ') with intravenous midazolam sedation for the management of the patient described in the clinical scenario. Discuss which technique you would select for the FIRST appointment and provide a clinical justification for your choice.' }),
          ],
          spacing: { before: 80, after: 80 },
          alignment: AlignmentType.JUSTIFIED,
        }),
        markBox('2', 'Structured comparison (1) + Clinically justified recommendation (1)'),
        emptyLine(),
        dividerLine(),

        // ==============================
        // MARK ALLOCATION TABLE
        // ==============================
        new Paragraph({
          children: [new TextRun({ text: 'MARK ALLOCATION SUMMARY', bold: true, size: 22, underline: { type: UnderlineType.SINGLE } })],
          alignment: AlignmentType.LEFT,
          spacing: { before: 200, after: 100 },
        }),
        createMarkTable(),
        emptyLine(),
        dividerLine(),
        emptyLine(),

        // ==============================
        // MODEL ANSWER SECTION
        // ==============================
        new Paragraph({
          children: [new TextRun({ text: 'MODEL ANSWER — EXAMINERS COPY', bold: true, size: 28, color: '2E75B6', underline: { type: UnderlineType.SINGLE } })],
          alignment: AlignmentType.CENTER,
          spacing: { before: 400, after: 200 },
        }),

        // PART A MODEL ANSWER
        heading1('PART A: PHARMACOLOGICAL BEHAVIOUR MANAGEMENT — DEFINITION AND CLASSIFICATION [5 Marks]'),

        heading2('Definition'),
        para('Pharmacological behaviour management refers to the use of pharmacological (drug-based) agents to modify a patient\'s emotional and physiological responses to dental treatment, reducing anxiety, pain, and undesirable movement, thereby facilitating the safe and effective delivery of dental care. It encompasses a spectrum of techniques ranging from mild preoperative anxiolysis to general anaesthesia (Girdler, Hill & Wilson, 2018; Malamed, 2018).'),

        heading2('Spectrum of Pharmacological Behaviour Management'),
        para('The management of dental anxiety sits within a broader spectrum. Non-pharmacological techniques (tell-show-do, hypnosis, cognitive-behavioural therapy) form the foundation, with pharmacological adjuncts added when non-pharmacological methods are insufficient.'),

        heading2('Classification by Route of Administration'),
        boldPara('I. Inhalation Sedation'),
        bullet('Nitrous oxide (N₂O) – oxygen sedation (relative analgesia)'),
        bullet('Only technique: no injectable route required'),

        boldPara('II. Enteral (Oral and Intranasal) Routes'),
        bullet('Oral premedication: diazepam, temazepam (mild anxiolysis)'),
        bullet('Oral sedation: higher-dose temazepam (30–40 mg), oral midazolam'),
        bullet('Intranasal sedation: intranasal midazolam (transmucosal)'),

        boldPara('III. Parenteral Routes'),
        bullet('Intravenous (IV) sedation: midazolam, diazepam (Diazemuls), propofol (specialist only)'),
        bullet('Intramuscular (IM): rarely used; ketamine in special circumstances'),
        bullet('Rectal: limited paediatric use'),

        boldPara('IV. General Anaesthesia'),
        bullet('Last resort; requires anaesthetist, theatre environment, full monitoring'),
        bullet('Inhalation (sevoflurane, isoflurane) and/or IV induction (propofol)'),

        heading2('Distinction Between Key Concepts'),
        para('Premedication: Drug given PRE-OPERATIVELY to achieve mild anxiolysis only; patient remains ambulant and communicative. Example: 10 mg oral temazepam, 1 hour pre-op.'),
        para('Conscious Sedation: A drug-induced depression of the CNS, enabling dental treatment to be carried out, but during which verbal communication is maintained and protective reflexes remain intact. Defined by the Academy of Medical Royal Colleges, UK (2013), and the ADA. The patient can respond purposefully to verbal commands throughout.'),
        para('General Anaesthesia (GA): Drug-induced loss of consciousness; patient cannot be roused, protective reflexes are lost. Requires airway management, anaesthetic team, and specialist environment. GA is NOT appropriate in primary dental care settings.'),

        emptyLine(),
        dividerLine(),

        // PART B MODEL ANSWER
        heading1('PART B (i): ORAL AND INTRANASAL SEDATION [5 Marks]'),

        heading2('Agents Used for Oral Premedication'),
        para('Diazepam: Available as 2 mg, 5 mg, 10 mg tablets. Standard anxiolytic dose: 0.1–0.25 mg/kg body weight, given 1 hour pre-operatively after a light snack. Elimination T½β = 43 hours (plus active metabolite N-desmethyldiazepam, T½β ≈ 72 hours), meaning rebound sedation is possible up to 72 hours post-dose.'),
        para('Temazepam: Now the most commonly used oral premedication agent. Dose: 10 mg standard dose; 20 mg for severely anxious adults. Elimination T½ ≈ 4 hours. More suitable than diazepam because of its shorter half-life and lower risk of rebound sedation.'),

        heading2('Agents Used for Oral Sedation'),
        para('Temazepam 30–40 mg orally produces a state of oral sedation (beyond simple premedication). Vital signs must be monitored throughout when used at these doses.'),
        para('Midazolam (oral): Elixir form, 0.5 mg/kg for children; for adults unlicensed preparation used in some countries. Onset 20–30 minutes; unpredictable due to first-pass hepatic metabolism. An IV cannula should always be placed as a precaution when using oral midazolam.'),

        heading2('Intranasal Sedation'),
        para('Intranasal midazolam bypasses first-pass hepatic metabolism by absorption across the nasal mucosa\'s rich vascular plexus, providing more predictable bioavailability than the oral route. Administered via nasal atomiser. Used for: patients with severe needle phobia, children with challenging behaviour, and adults with learning disabilities. An IV cannula should be inserted once adequate sedation is achieved (for emergency reversal with flumazenil if required).'),

        heading2('Mechanism of Action: Benzodiazepines at the GABA-A Receptor'),
        para('The GABA (gamma-aminobutyric acid) system is the principal inhibitory neurotransmitter system in the CNS. GABA binds to GABA-A receptors, opening chloride ion channels, causing hyperpolarisation and decreased neuronal excitability. Benzodiazepines (BDZs) bind to a specific allosteric site on the GABA-A receptor complex (the BDZ receptor site), adjacent to but distinct from the GABA binding site. BDZ binding increases the FREQUENCY of chloride channel opening in response to GABA, thereby potentiating GABA-mediated inhibition. This results in: sedation, anxiolysis, amnesia (anterograde), muscle relaxation, and anticonvulsant effects (Girdler et al, 2018).'),

        heading2('Advantages and Limitations of Oral/Intranasal vs IV Sedation'),
        boldPara('Advantages of oral/intranasal routes:'),
        bullet('Non-invasive; no injection required'),
        bullet('Useful for needle-phobic patients'),
        bullet('Lower operator skill threshold'),
        bullet('Applicable in primary care settings'),
        boldPara('Limitations:'),
        bullet('Non-titratable: cannot adjust depth during procedure'),
        bullet('Variable absorption (first-pass metabolism for oral route)'),
        bullet('Unpredictable onset and duration'),
        bullet('No reversal possible once absorbed (unlike IV where flumazenil can be given)'),
        bullet('Not suitable for deeply anxious patients or complex surgical procedures'),

        emptyLine(),
        dividerLine(),

        // PART B(ii)
        heading1('PART B (ii): INTRAVENOUS SEDATION AGENTS [8 Marks]'),

        heading2('Midazolam (Drug of Choice for IV Sedation in UK Dentistry)'),
        para('Midazolam is an imidazobenzodiazepine. It is water-soluble at pH < 4.0 but becomes lipid-soluble at physiological pH (7.4), enabling rapid penetration of the blood–brain barrier. It is non-irritant to veins.'),

        boldPara('Pharmacokinetics of Midazolam:'),
        bullet('Presentation: 1 mg/ml (5 ml ampoule) for dental IV sedation in UK'),
        bullet('Onset: Clinical effect within 20–30 seconds (arm-to-brain circulation time ≈ 1 minute; clinical effect develops over 1–2 minutes)'),
        bullet('Distribution T½α: 15–30 minutes'),
        bullet('Elimination T½β: 1.9 hours (±0.9 hours)'),
        bullet('Active metabolite: 1-hydroxymidazolam (T½ = 1.25 hours); explains slower initial recovery than pharmacokinetics alone predict'),
        bullet('Dose: 0.07–0.1 mg/kg; titrated in incremental IV doses'),
        bullet('Potency: 2.5 times more potent than diazepam'),
        bullet('Amnesia: More reliable anterograde amnesia than diazepam'),
        bullet('No rebound sedation (unlike diazepam)'),

        heading2('Diazepam (Historical Use; Now Largely Superseded)'),
        para('Diazepam is almost insoluble in water; formulated as Diazemuls (emulsified in soya bean oil) to reduce venous irritation. Dose: 0.1–0.2 mg/kg.'),
        bullet('Distribution T½α: 40 minutes'),
        bullet('Elimination T½β: 43 hours (±13 hours)'),
        bullet('Active metabolite: N-desmethyldiazepam with T½β ≈ 72 hours — risk of REBOUND SEDATION up to 72 hours post-administration. This makes diazepam poorly suited for outpatient dental sedation.'),

        heading2('Comparison Table: Midazolam vs Diazepam'),
        new Table({
          width: { size: 100, type: WidthType.PERCENTAGE },
          borders: {
            top: { style: BorderStyle.SINGLE, size: 1 },
            bottom: { style: BorderStyle.SINGLE, size: 1 },
            left: { style: BorderStyle.SINGLE, size: 1 },
            right: { style: BorderStyle.SINGLE, size: 1 },
            insideH: { style: BorderStyle.SINGLE, size: 1 },
            insideV: { style: BorderStyle.SINGLE, size: 1 },
          },
          rows: [
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Parameter', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'BDD7EE', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Midazolam', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'BDD7EE', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Diazepam (Diazemuls)', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'BDD7EE', type: ShadingType.SOLID } }),
              ],
            }),
            ...([
              ['Presentation', '1 mg/ml (water soluble)', '5 mg/ml (emulsified in soya bean oil)'],
              ['Standard dose', '0.07–0.1 mg/kg', '0.1–0.2 mg/kg'],
              ['T½α (distribution)', '15–30 minutes', '~40 minutes'],
              ['T½β (elimination)', '1.9 hrs ± 0.9 hrs', '43 hrs ± 13 hrs'],
              ['Active metabolite', '1-hydroxymidazolam (T½ 1.25 hrs)', 'N-desmethyldiazepam (T½ ~72 hrs)'],
              ['Rebound sedation', 'Not clinically significant', 'Yes, up to 72 hours'],
              ['Relative potency', '2.5× more potent than diazepam', 'Reference standard'],
              ['Amnesia', 'Reliable anterograde amnesia', 'Less reliable'],
              ['Current use in UK', 'Drug of CHOICE', 'Largely superseded'],
            ].map(row => new TableRow({
              children: row.map((cell, idx) => new TableCell({
                children: [new Paragraph({ children: [new TextRun({ text: cell, bold: idx === 0 })], alignment: AlignmentType.LEFT })],
              })),
            }))),
          ],
        }),

        heading2('Flumazenil — Benzodiazepine Antagonist'),
        para('Flumazenil is a true benzodiazepine that lacks the benzene ring attached to the diazepine moiety, abolishing intrinsic agonist activity. It has greater affinity for the BDZ receptor than virtually all known agonists, acting as a competitive antagonist. It rapidly reverses benzodiazepine-induced sedation, respiratory depression, and amnesia.'),
        bullet('Presentation: 500 mcg/ml in 5 ml ampoules (IV)'),
        bullet('Administration: 200 mcg IV, then 100 mcg/min until recovery; maximum dose ≈ 1 mg'),
        bullet('T½β: 53 minutes (±13 minutes) — SHORTER than the benzodiazepines it reverses'),
        bullet('Risk of re-sedation if benzodiazepine T½ exceeds that of flumazenil (important for diazepam)'),
        bullet('Use: Emergency situations ONLY; not recommended for routine reversal due to cost, risk of abrupt awakening, and theoretical re-sedation risk'),
        para('Clinical note for this patient: Flumazenil should be available in any dental practice performing IV benzodiazepine sedation.'),

        heading2('Propofol — Emerging Agent (Specialist Use Only)'),
        para('Propofol (2,6-diisopropylphenol) is a potent intravenous hypnotic that enhances GABA neurotransmission, similar to benzodiazepines. It produces rapid, smooth induction (within minutes) and rapid clearance, with patients fully recovered 10–15 minutes after cessation of infusion.'),
        bullet('Advantages: Rapid, smooth onset; quick, high-quality recovery; moderate amnesia'),
        bullet('Disadvantages: Narrow margin of safety between sedation and GA; requires infusion pump (target-controlled infusion, TCI); injection pain; not licensed for routine dental sedation'),
        bullet('Restriction: Use of propofol for dental sedation is ONLY recommended for specialist anaesthetists in the UK (Girdler et al, 2018)'),

        emptyLine(),
        dividerLine(),

        // PART C(i)
        heading1('PART C (i): PHARMACOLOGY AND PHYSICAL PROPERTIES OF NITROUS OXIDE [7 Marks]'),

        heading2('Preparation and Physical Properties'),
        para('Nitrous oxide (N₂O; dinitrogen monoxide) is prepared commercially by heating ammonium nitrate crystals to 240°C, yielding N₂O and water vapour. The gas is chemically scrubbed to remove impurities (NO, NO₂, NH₄, CO, water vapour) and compressed to ≥99.5% purity (US Pharmacopeia minimum 97%).'),
        bullet('Physical state: Colourless, faintly sweet-smelling gas at room temperature'),
        bullet('Storage: Stored as a LIQUID under pressure in light-blue cylinders'),
        bullet('Cylinder pressure: 750 psi (43.5 bar) — remains constant until almost all liquid has evaporated; cylinder contents assessed by WEIGHT, not pressure gauge'),
        bullet('Cylinder colour coding: N₂O — BLUE; O₂ — BLACK with white shoulders (UK)'),
        bullet('Specific gravity: 1.53'),
        bullet('NOT flammable but SUPPORTS combustion'),

        heading2('Solubility: Blood-Gas Partition Coefficient'),
        para('N₂O has a blood-gas partition coefficient of 0.47, making it relatively insoluble in blood. This low solubility is the key to its clinical utility:'),
        bullet('RAPID ONSET: Small quantities dissolve in blood → alveolar partial pressure rises quickly → fast equilibration with brain → fast onset of sedation (2–3 minutes)'),
        bullet('RAPID RECOVERY: Upon cessation, N₂O rapidly leaves the blood into the alveoli → fast recovery (3–5 minutes)'),
        bullet('N₂O is not metabolised by the body and is exhaled virtually unchanged (with approximately 1% excreted via lungs/skin over 24 hours)'),

        heading2('Minimum Alveolar Concentration (MAC) and Potency'),
        para('MAC is defined as the inspired alveolar concentration that, at equilibrium, prevents purposeful movement in response to a standard surgical stimulus in 50% of subjects. The MAC of N₂O is approximately 105%, meaning:'),
        bullet('N₂O is the LEAST POTENT inhalation agent'),
        bullet('Surgical-depth anaesthesia is IMPOSSIBLE with N₂O alone at normal atmospheric pressure (because to reach MAC of 105%, one would need to eliminate all oxygen, causing fatal hypoxia)'),
        bullet('With a minimum 20% O₂ maintained (as required by all inhalation sedation machines), maximum deliverable N₂O ≈ 70–80% — safely below MAC'),
        bullet('Dentistry uses: 20–50% N₂O; levels > 50% risk entering light anaesthesia (Plane III / Stage II)'),

        heading2('Analgesic Properties'),
        para('N₂O is a "fairly potent analgesic" (Girdler et al, 2018). A 50% N₂O concentration produces analgesia equivalent to 10–15 mg of parenteral morphine (Malamed, 2018). This analgesic effect reduces the discomfort of local anaesthetic injections and makes N₂O particularly useful for minor procedures that do not require full anaesthesia.'),

        heading2('Diffusion Hypoxia'),
        para('At the end of N₂O administration, N₂O rapidly exits the bloodstream into the alveoli (reverse of induction). The large volumes of N₂O flooding the alveoli displace oxygen and nitrogen, effectively diluting the alveolar O₂ concentration. If the patient breathes room air (21% O₂), the alveolar O₂ may fall sufficiently to cause hypoxaemia — this is diffusion hypoxia (the Fink effect). To prevent this: 100% O₂ is administered for a minimum of 3–5 minutes at the end of all N₂O sedation sessions. This is mandatory.'),

        heading2('Cardiovascular and Respiratory Effects'),
        para('N₂O produces minimal cardiovascular effects: minor increase in heart rate early (anxiety relief) returning to baseline; mild decrease in myocardial contractility in high concentrations. Respiratory: slight depression of the hypoxic ventilatory response; no clinically significant respiratory depression at sedation concentrations when ≥30% O₂ is maintained.'),

        emptyLine(),
        dividerLine(),

        // PART C(ii)
        heading1('PART C (ii): INDICATIONS, CONTRAINDICATIONS AND PATIENT SELECTION [5 Marks]'),

        heading2('Indications for N₂O-O₂ Inhalation Sedation'),
        bullet('Dental anxiety (children and adults) — primary indication'),
        bullet('Needle phobia — allows dental treatment without IV cannulation; also used to facilitate IV cannulation in needle-phobic patients who need IV sedation'),
        bullet('Management of gag reflex — N₂O reduces gag sensitivity at Plane II concentrations'),
        bullet('Medically compromised patients:'),
        indentedPara('• Cardiovascular disease: N₂O provides elevated O₂ (30–70%), reducing myocardial O₂ demand; used in acute angina/MI in emergency medicine (Entonox)'),
        indentedPara('• Asthma (well-controlled): N₂O-O₂ is SPECIFICALLY INDICATED — guaranteed 30%+ O₂; no respiratory depressant effects; easily reversible. This patient\'s well-controlled asthma is NOT a contraindication.'),
        indentedPara('• Haematological disorders (sickle cell anaemia, thalassaemia): Inhalation sedation provides elevated O₂, preventing hypoxic crises. IV sedation is more risky in these patients.'),
        indentedPara('• Hepatic disease: N₂O is not metabolised by the liver — safe to use'),
        indentedPara('• Epilepsy/CVA: Elevated O₂ provision is neuroprotective'),
        bullet('Patients who are needle-phobic (cannot accept venepuncture)'),
        bullet('Paediatric dentistry — minimum age ≈ 3 years (requires cooperation and nasal breathing)'),
        bullet('Simple restorative, periodontal, surgical, endodontic, and orthodontic procedures'),

        heading2('Contraindications'),
        boldPara('Relative Contraindications (not absolute):'),
        bullet('Upper respiratory tract infections / blocked nose (cannot deliver gas nasally)'),
        bullet('Enlarged tonsils or adenoids'),
        bullet('Chronic obstructive pulmonary disease (COPD) — hypoxic drive dependent on reduced O₂; N₂O can suppress this'),
        bullet('Severe psychiatric disorders — altering consciousness may be unpredictable/harmful'),
        bullet('Mouth breathers (gas inhaled through mouth, not nose — ineffective delivery)'),
        bullet('Very young children (<3 years) — insufficient cooperation'),
        bullet('Severe learning difficulties (unable to cooperate)'),
        bullet('Claustrophobia (nasal mask may trigger response)'),
        bullet('Pregnancy: (First and third trimester particularly) — relative contraindication; obstetrician consultation required'),
        bullet('Patients taking mood-altering medications (psychotropic drugs) — caution'),
        bullet('Active middle ear disease / recent ophthalmic gas bubble surgery — N₂O expands gas-filled spaces (Boyle\'s law)'),

        heading2('Patient Selection for This Clinical Scenario'),
        para('The described patient is an excellent candidate for N₂O-O₂ inhalation sedation:'),
        bullet('Severe dental anxiety (MCDAS score 15) — primary indication'),
        bullet('Needle phobia — can facilitate the first appointment without any injection; can later facilitate IV cannulation for IV sedation if needed for the surgical extractions'),
        bullet('Well-controlled asthma on salbutamol — N₂O specifically indicated; guaranteed elevated O₂ minimises asthma risk'),
        bullet('BP 128/82 (ASA I) — no contraindication to sedation'),
        bullet('No listed contraindications for inhalation sedation'),
        bullet('Recommendation: N₂O-O₂ inhalation sedation for initial restorative appointments; may progress to IV midazolam sedation (combined technique) for molar extractions'),

        emptyLine(),
        dividerLine(),

        // PART C(iii)
        heading1('PART C (iii): EQUIPMENT AND SAFETY FEATURES [6 Marks]'),

        heading2('Components of the Inhalation Sedation Unit'),
        para('Modern dental inhalation sedation units are continuous-flow machines. Components include:'),
        numberedPara('Gas cylinders: N₂O (blue) and O₂ (black/white) cylinders. Portable systems use E-cylinders; central systems use larger G/H cylinders stored remotely.', 1),
        numberedPara('Pressure-reducing valves (regulators): Reduce high cylinder pressure to a usable working pressure for the flowmeters.', 2),
        numberedPara('Pressure gauges: Display cylinder content. Note: O₂ cylinder pressure accurately reflects content; N₂O cylinder pressure does NOT (liquid storage — must be WEIGHED).', 3),
        numberedPara('Flowmeters (rotameters): Calibrated tubes displaying the actual flow rate (litres/min) of each gas individually. Accuracy to within ±2%.', 4),
        numberedPara('Mixing head / concentration dials: Controls the ratio of N₂O to O₂. Some systems show O₂% directly; others have separate N₂O and O₂ knobs.', 5),
        numberedPara('Reservoir bag: Latex-free. Indicates adequacy of gas flow (¾ full = correct), acts as monitoring aid for respiration, and allows manual positive-pressure ventilation in emergencies.', 6),
        numberedPara('Conducting tubing and one-way valves: Prevent rebreathing of exhaled gas.', 7),
        numberedPara('Nasal mask (hood): Available in multiple sizes; scavenging models have inner/outer chambers. Fits over nose only.', 8),
        numberedPara('Scavenging system: Active vacuum removes expired N₂O at ≥45 L/min from the nasal hood.', 9),

        heading2('Mandatory Safety Features'),
        boldPara('1. Minimum Oxygen Delivery (30% O₂)'),
        para('The machine is designed so that O₂ delivery can NEVER fall below 30% of total gas flow, regardless of any setting. This ensures the patient always breathes a gas mixture richer in O₂ than room air (21%), preventing hypoxia and making anaesthesia virtually impossible.'),

        boldPara('2. Automatic Gas Cut-Out (Fail-Safe)'),
        para('If the O₂ supply fails or O₂ pressure drops below a threshold, N₂O delivery is automatically cut off. This prevents the inadvertent administration of 100% N₂O.'),

        boldPara('3. Pin Index Safety System (PISS)'),
        para('On free-standing units, cylinders are attached via yoke fittings. Each gas has a unique pin configuration on the valve block that matches only the correct yoke, making it physically impossible to attach an N₂O cylinder to the O₂ yoke and vice versa.'),

        boldPara('4. Diameter Index Safety System (DISS)'),
        para('For piped systems: each wall outlet has a unique diameter connector specific to each gas, preventing wrong connections.'),

        boldPara('5. Colour Coding'),
        para('All components associated with N₂O are coloured BLUE; all O₂ components are coloured BLACK (with white shoulders for UK cylinders). This applies to tubing, flowmeter labels, and cylinder fittings.'),

        boldPara('6. Oxygen Flush Button'),
        para('Instantly delivers 100% O₂ at high flow to the patient in case of over-sedation or emergency.'),

        boldPara('7. Air Entrainment Valve'),
        para('If gas flow falls below the patient\'s minute volume, an air entrainment valve opens, allowing room air to supplement delivery and preventing the patient from breathing against a closed system.'),

        boldPara('8. Audible Alarm'),
        para('An alarm alerts the operator when oxygen levels fall below a safe threshold.'),

        boldPara('9. Active Scavenging'),
        para('Statutory requirement in UK. Removes expired N₂O from the breathing circuit at ≥45 L/min airflow, preventing surgery contamination.'),

        heading2('Free-Standing vs Piped Central System'),
        para('Free-standing (portable): Self-contained with own E-cylinders; movable between surgeries; lower initial cost; cylinders require more frequent replacement. Central (piped): Gas stored remotely; delivered via copper pipes to wall outlets; uses larger, more economical cylinders; lower long-term gas cost; ideal for high-frequency N₂O use in specialist or paediatric practices.'),

        emptyLine(),
        dividerLine(),

        // PART C(iv)
        heading1('PART C (iv): TECHNIQUE OF ADMINISTRATION AND PLANES OF ANALGESIA [7 Marks]'),

        heading2('Patient Preparation and Pre-Operative Checks'),
        bullet('Assessment appointment: history, examination, vital signs (BP, HR, SpO₂), anxiety score, consent'),
        bullet('Written instructions: light meal 2 hours pre-procedure; no alcohol for 24 hours'),
        bullet('Equipment check: gas levels (O₂ by pressure; N₂O by weight), leak test, cut-out test, O₂ flush test'),
        bullet('Patient escort: not mandatory for adults receiving inhalation sedation only; children must have responsible adult'),
        bullet('Informed written consent: obtained at assessment; reconfirmed on day'),

        heading2('Step-by-Step Technique of Administration'),
        numberedPara('Recline patient to supine. Connect pre-checked machine and confirm scavenging is operational.', 1),
        numberedPara('Show nasal mask to patient; explain sensations (warmth, tingling, relaxation) — use positive, non-specific terminology. Allow patient to hold mask initially.', 2),
        numberedPara('Set 100% O₂ at 4–6 L/min (adults: 6 L/min; children: 3–4 L/min). Place mask over nose. Ask patient to breathe through nose with mouth closed. Adjust to achieve comfortable minute volume (reservoir bag ¾ full).', 3),
        numberedPara('After 1–2 minutes of 100% O₂, introduce 10% N₂O (90% O₂). Inform patient of expected sensations.', 4),
        numberedPara('After 1 minute, increase to 20% N₂O. Observe reservoir bag and patient response continuously. Use hypnotic suggestion and positive reinforcement throughout — speak in low, monotone voice; use story-telling or progressive relaxation.', 5),
        numberedPara('Titrate in 5–10% increments every 60–90 seconds, until adequate sedation is achieved. Average adult: 30% N₂O (range 20–50%). NEVER exceed 70% N₂O. Ask patient open-ended questions: "What are you feeling?"', 6),
        numberedPara('Signs of adequate sedation: general relaxation, reduced fidgeting, paraesthesia of fingers/toes/lips, slowed but coherent verbal responses, reduced reaction to stimuli. Patient confirms comfort.', 7),
        numberedPara('Administer topical anaesthetic, then local anaesthesia. Continue N₂O-O₂ throughout treatment. If patient mouth-breathes (dilutes gas), encourage nasal breathing or briefly pause treatment. NEVER use mouth props.', 8),
        numberedPara('At procedure end: turn off N₂O; return to 100% O₂ at original flow rate. Administer for minimum 3–5 minutes (prevents diffusion hypoxia).', 9),
        numberedPara('Discharge criteria: Coherent, oriented, steady gait, vital signs within ±15–20 mmHg systolic of baseline; SpO₂ returned to baseline. Use Trieger test (fine motor coordination) for objective assessment.', 10),
        numberedPara('Complete sedation records: percentage N₂O used, flow rates, start/end times, post-operative O₂ time, patient cooperation, written post-op instructions.', 11),

        heading2('Techniques of Gas Delivery'),
        boldPara('Constant Liter Flow Technique:'),
        para('Total gas flow remains constant. N₂O increased 1 L/min and O₂ decreased 1 L/min simultaneously; subsequent increments of 0.5 L/min each. Advantage: lower gas consumption (more economical). Disadvantage: N₂O percentage increments are fixed and larger, increasing risk of oversedation.'),
        boldPara('Constant O₂ Flow Technique:'),
        para('O₂ flow remains constant throughout; N₂O increased by 1 L/min increments. Advantage: each increment represents a DECREASING percentage of N₂O as total flow rises — self-limiting titration, reduced oversedation risk; easier to use (one dial adjustment). Disadvantage: uses more gas overall.'),

        heading2('Planes of Analgesia (Guedel Stage I Subdivisions)'),
        para('The clinical effects of N₂O are described using the planes of analgesia derived from Guedel\'s stages of anaesthesia. Stage I (analgesia) is divided into three planes:'),

        new Table({
          width: { size: 100, type: WidthType.PERCENTAGE },
          borders: {
            top: { style: BorderStyle.SINGLE, size: 1 },
            bottom: { style: BorderStyle.SINGLE, size: 1 },
            left: { style: BorderStyle.SINGLE, size: 1 },
            right: { style: BorderStyle.SINGLE, size: 1 },
            insideH: { style: BorderStyle.SINGLE, size: 1 },
            insideV: { style: BorderStyle.SINGLE, size: 1 },
          },
          rows: [
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Plane', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 10, type: WidthType.PERCENTAGE } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'N₂O Concentration', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 18, type: WidthType.PERCENTAGE } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Subjective Symptoms', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 36, type: WidthType.PERCENTAGE } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Objective Signs', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 36, type: WidthType.PERCENTAGE } }),
              ],
            }),
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Plane I', bold: true, color: '1F6B0A' })], alignment: AlignmentType.CENTER })], shading: { fill: 'E2EFDA', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: '5–25%', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'E2EFDA', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Relaxation; sense of well-being; tingling in fingers/toes/cheeks; warm sensation; lightheadedness; euphoria; analgesia begins; alert' })] })], shading: { fill: 'E2EFDA', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Normal vital signs; alert; responds normally; slight reduction in spontaneous movement; normal reflexes; normal pupils; analgesia' })] })], shading: { fill: 'E2EFDA', type: ShadingType.SOLID } }),
              ],
            }),
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Plane II', bold: true, color: 'B8860B' })], alignment: AlignmentType.CENTER })], shading: { fill: 'FFF2CC', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: '20–55%', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'FFF2CC', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Marked relaxation; sleepiness; detachment from environment; altered senses; possible dreaming; widespread paraesthesia; moderate analgesia; reduced gag reflex' })] })], shading: { fill: 'FFF2CC', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Delayed response to questioning; reduced spontaneous movement; vital signs and laryngeal reflexes NORMAL; reduced gag reflex; "sedated look"' })] })], shading: { fill: 'FFF2CC', type: ShadingType.SOLID } }),
              ],
            }),
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Plane III', bold: true, color: 'C00000' })], alignment: AlignmentType.CENTER })], shading: { fill: 'FFE7E7', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: '>50% (DANGER ZONE)', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'FFE7E7', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Marked sleepiness; nausea/dizziness; complete analgesia; possible dreaming/hallucinations; difficulty following commands' })] })], shading: { fill: 'FFE7E7', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: '"Glazed" appearance; unresponsive to questioning; nausea/vomiting common; may lose consciousness → enters Stage II GA. REDUCE N₂O IMMEDIATELY.' })] })], shading: { fill: 'FFE7E7', type: ShadingType.SOLID } }),
              ],
            }),
          ],
        }),

        emptyLine(),
        para('Note: Most clinically useful sedation occurs in Plane I and lower Plane II. Plane III is a transition zone and a clinical warning to reduce N₂O. Individual variation is marked — some patients sedate adequately at 10%, others require >50%.'),

        heading2('Role of Hypnotic Suggestion'),
        para('N₂O produces psycho-pharmacological sedation — a combination of pharmacological drug effect and psychological suggestion. The pharmacological properties of N₂O lower the threshold for suggestion. The dentist\'s use of monotone, positive verbal reassurance, distraction techniques, and progressive relaxation scripts amplifies the sedative effect and improves patient cooperation. This is unlike IV midazolam, which produces pharmacological sedation independent of suggestion. The success of inhalation sedation depends as much on the operator\'s communication skills as on the drug itself (Girdler et al, 2018).'),

        emptyLine(),
        dividerLine(),

        // PART C(v)
        heading1('PART C (v): COMPLICATIONS, OCCUPATIONAL HAZARDS AND POLLUTION CONTROL [5 Marks]'),

        heading2('Acute Complications'),
        boldPara('1. Over-sedation'),
        para('The most common acute complication. Clinical indicators: persistent mouth closure, incoherent speech, patient dreaming/unresponsive, sudden jerking movements ("falling" sensation), nausea. Management: reduce N₂O by 5–10% (0.5–1.0 L/min); administer 100% O₂; reassure patient. Do NOT use mouth props. Reduce N₂O BEFORE increasing O₂.'),

        boldPara('2. Nausea and Vomiting (N&V)'),
        para('Incidence < 0.5% with correct technique (Malamed, 2018). Causes: heavy pre-operative meal; over-sedation; "roller coaster" fluctuations in N₂O level; prolonged sedation; empty stomach. Management of nausea: reduce N₂O by 0.5–1.0 L/min. Management of vomiting: turn off N₂O; remove nasal hood; remove dental dam and instruments from mouth; turn patient\'s head to side; use suction; administer 100% O₂; 4×4 gauze for clearance.'),

        boldPara('3. Diffusion Hypoxia'),
        para('Occurs at termination of N₂O delivery if patient breathes room air (see Part C(i)). Prevention: MANDATORY 100% O₂ for 3–5 minutes post-procedure. Failure causes: headache, nausea, lethargy — the N₂O "hangover."'),

        boldPara('4. Equipment Failure'),
        para('Causes: gas cylinder running out; machine malfunction; leak in circuit (check reservoir bag); failure of scavenging. Prevention: pre-use equipment checklist; weigh N₂O cylinders; check O₂ pressure; test cut-out and flush buttons.'),

        boldPara('5. Other Acute Complications'),
        bullet('Claustrophobia precipitated by the nasal mask'),
        bullet('Contact lens irritation from dry gas — patients should remove lenses before treatment'),
        bullet('N₂O expansion into closed body spaces (middle ear, bowel gas, pneumothorax, intraocular gas bubbles) — contraindicated with intraocular gas (risk of blindness)'),

        heading2('Chronic Occupational Hazards'),
        para('The major concern with N₂O is the chronic exposure of dental personnel. N₂O exerts its toxic effects through OXIDATION OF COBALT in vitamin B₁₂, thereby INACTIVATING METHIONINE SYNTHASE.'),

        boldPara('Methionine Synthase Pathway:'),
        para('N₂O → Oxidises vitamin B₁₂ cobalt (Co⁺ → Co²⁺) → Inactivates methionine synthase → Impairs conversion of homocysteine to methionine → Impairs tetrahydrofolate production → Reduced DNA synthesis (folate trap) → Cell division impairment.'),
        para('A 50% reduction in methionine synthase activity occurs within 45–90 minutes of 70% N₂O exposure (Malamed, 2018).'),

        boldPara('Clinical Manifestations of Chronic Exposure:'),
        new Table({
          width: { size: 100, type: WidthType.PERCENTAGE },
          borders: {
            top: { style: BorderStyle.SINGLE, size: 1 },
            bottom: { style: BorderStyle.SINGLE, size: 1 },
            left: { style: BorderStyle.SINGLE, size: 1 },
            right: { style: BorderStyle.SINGLE, size: 1 },
            insideH: { style: BorderStyle.SINGLE, size: 1 },
            insideV: { style: BorderStyle.SINGLE, size: 1 },
          },
          rows: [
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'System', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'BDD7EE', type: ShadingType.SOLID } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Effect', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: 'BDD7EE', type: ShadingType.SOLID } }),
              ],
            }),
            ...([
              ['Haematological', 'Pernicious anaemia-like picture; impaired bone marrow function; leukopenia; megaloblastic erythropoiesis (long-term exposure > 24 hrs)'],
              ['Neurological', 'Myeloneuropathy; paraesthesias; dysaesthesias; sensory and proprioception impairment; weakness (resembles vitamin B₁₂ deficiency neuropathy)'],
              ['Reproductive', 'Increased risk of spontaneous abortion; reduced fertility in women; reported in dental staff with unscavenged N₂O exposure (Sweeney et al)'],
              ['Hepatic/Renal', 'Impaired function at very high/prolonged exposures'],
              ['Oncological', 'Theoretical increased malignancy risk — not conclusively established'],
            ].map(row => new TableRow({
              children: row.map((cell, idx) => new TableCell({
                children: [new Paragraph({ children: [new TextRun({ text: cell, bold: idx === 0 })] })],
              })),
            }))),
          ],
        }),

        heading2('N₂O Exposure Limits and Pollution Control'),
        boldPara('Regulatory Limits (NIOSH):'),
        bullet('Operating rooms: 25 ppm N₂O (time-weighted average)'),
        bullet('Dental offices: 50 ppm N₂O (NIOSH recommendation)'),
        bullet('Sweeney et al: 400 ppm is a reasonable safe exposure level for dental settings — biologically inactive'),
        bullet('September 1995 ADA meeting concluded: no definitive maximum exposure limit has been established based on current evidence'),

        boldPara('Methods to Reduce N₂O Pollution:'),
        bullet('Active scavenging: STATUTORY REQUIREMENT in UK. Scavenging nasal hood (double-mask design) removes all exhaled gas at ≥45 L/min into vacuum. Standard of care for all inhalation sedation procedures.'),
        bullet('Passive ventilation: Open windows/doors; floor-level fan ventilation to exterior'),
        bullet('Good technique: Proper mask seal; discourage patient from talking during treatment; minimise mouth-breathing; select appropriate nasal mask size'),
        bullet('Infrared N₂O analyser: Most accurate method; measures ambient N₂O to 1 ppm; recommended for monitoring compliance'),
        bullet('Legal/occupational compliance: UK COSHH regulations apply; pregnant staff and staff trying to conceive must NOT work in surgeries where N₂O is used'),

        emptyLine(),
        dividerLine(),

        // PART D
        heading1('PART D: CRITICAL COMPARISON — INHALATION SEDATION vs IV MIDAZOLAM SEDATION [2 Marks]'),

        para('For this patient (severe anxiety, needle phobia, well-controlled asthma, multiple treatment needs across multiple appointments), the two most relevant techniques are compared:'),

        new Table({
          width: { size: 100, type: WidthType.PERCENTAGE },
          borders: {
            top: { style: BorderStyle.SINGLE, size: 1 },
            bottom: { style: BorderStyle.SINGLE, size: 1 },
            left: { style: BorderStyle.SINGLE, size: 1 },
            right: { style: BorderStyle.SINGLE, size: 1 },
            insideH: { style: BorderStyle.SINGLE, size: 1 },
            insideV: { style: BorderStyle.SINGLE, size: 1 },
          },
          rows: [
            new TableRow({
              children: [
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'Feature', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 30, type: WidthType.PERCENTAGE } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'N₂O-O₂ Inhalation', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 35, type: WidthType.PERCENTAGE } }),
                new TableCell({ children: [new Paragraph({ children: [new TextRun({ text: 'IV Midazolam', bold: true })], alignment: AlignmentType.CENTER })], shading: { fill: '2E75B6', type: ShadingType.SOLID }, width: { size: 35, type: WidthType.PERCENTAGE } }),
              ],
            }),
            ...([
              ['Route', 'Non-invasive; no injection', 'Requires IV cannulation'],
              ['Needle phobia', 'Ideal — no injection needed', 'Problematic; may need pre-treatment with inhalation sedation first'],
              ['Depth of sedation', 'Psycho-pharmacological; mild-moderate', 'Pharmacological; more profound'],
              ['Titratability', 'Fully titratable in real time', 'Titrated increments (slower; cannot reverse)'],
              ['Reversibility', 'Immediate (turn off gas)', 'Flumazenil (incomplete; re-sedation risk)'],
              ['Recovery time', '3–5 minutes; patient can drive', '>2 hours; escort required'],
              ['Amnesia', 'Minimal/none', 'Reliable anterograde amnesia'],
              ['Analgesia', 'Yes (≈morphine 10–15 mg at 50%)', 'No direct analgesia'],
              ['Asthma (this patient)', 'Specifically indicated (elevated O₂)', 'Caution with respiratory depressants'],
              ['Suitability for surgery (extractions)', 'Adequate for simple extractions', 'Better for traumatic/lengthy surgical procedures'],
            ].map(row => new TableRow({
              children: row.map((cell, idx) => new TableCell({
                children: [new Paragraph({ children: [new TextRun({ text: cell, bold: idx === 0 })] })],
              })),
            }))),
          ],
        }),

        heading2('Recommended Approach for First Appointment'),
        para('N₂O-O₂ inhalation sedation is the PREFERRED technique for this patient\'s FIRST appointment. Justification:'),
        bullet('Needle phobia precludes IV cannulation without prior sedation'),
        bullet('Asthma (well-controlled): inhalation sedation specifically indicated; elevated O₂ delivery is protective'),
        bullet('Non-invasive: builds trust and cooperation for subsequent appointments'),
        bullet('Fully titratable and immediately reversible — maximises safety'),
        bullet('Rapid recovery: no escort required; can return to normal activities'),
        para('For subsequent appointments requiring extractions, the combined technique may be employed: N₂O-O₂ is used to achieve anxiolysis and facilitate IV cannulation, followed by IV midazolam sedation for more profound sedation during the surgical procedure (Girdler et al, 2018).'),

        emptyLine(),
        dividerLine(),

        // ==============================
        // REFERENCES
        // ==============================
        heading1('REFERENCES'),
        para('The following references should be cited in the answer for maximum marks:'),
        emptyLine(),
        bullet('Girdler NM, Hill CM, Wilson KE. (2018). Conscious Sedation for Dentistry (2nd ed.). Hoboken, NJ: John Wiley & Sons. [Primary reference — entire answer draws from this text]'),
        bullet('Malamed SF. (2018). Sedation: A Guide to Patient Management (6th ed.). St. Louis: Mosby/Elsevier. [Chapters 11–17; pharmacology, rationale, technique of administration, complications, occupational hazards]'),
        bullet('Clark MS, Brunick AL. (2015). Handbook of Nitrous Oxide and Oxygen Sedation (4th ed.). St. Louis: Mosby. [Equipment, technique, safety]'),
        bullet('Academy of Medical Royal Colleges / Royal College of Surgeons of England. (2013). Safe Sedation Practice for Healthcare Procedures: Standards and Guidance. London: AOMRC.'),
        bullet('American Dental Association. (2016). Guidelines for Teaching Pain Control and Sedation to Dentists and Dental Students. Chicago: ADA.'),
        bullet('National Institute for Occupational Safety and Health (NIOSH). (1994). Nitrous Oxide: Controlling Exposures in the Dental Operatory. DHHS (NIOSH) Publication No. 94-100.'),
        bullet('Health and Safety Commission. (1995). Anaesthetic Agents: Controlling Exposure under COSHH. London: HMSO.'),
        bullet('Goodchild CS. (1993). GABA receptors and benzodiazepines. British Journal of Anaesthesia, 71(1), 127–133.'),
        bullet('Maze M, Fujinaga M. (2000). Recent advances in understanding the actions and toxicity of nitrous oxide. Anaesthesia, 55, 311–314.'),
        bullet('Sweeney B, Bingham RM, Amos RJ, Petty AC, Cole PV. (1985). Toxicity of bone marrow in dentists exposed to nitrous oxide. British Medical Journal, 291, 567–569.'),
        bullet('Donaldson M, Donaldson D, Quarnstrom FC. (2012). Nitrous oxide-oxygen administration: when safety features no longer are safe. Journal of the American Dental Association, 143(2), 134–143.'),
        bullet('Mallampati SR et al. (1985). A clinical sign to predict difficult tracheal intubation: a prospective study. Canadian Anaesthetists\' Society Journal, 32(4), 429–434.'),
        bullet('Weimann J. (2003). Toxicity of nitrous oxide. Best Practice and Research in Clinical Anaesthesiology, 17(1), 47–61.'),
        bullet('Fernandez-Guisasola J et al. (2010). Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis. Anaesthesia, 65(4), 379–387.'),
        emptyLine(),
        dividerLine(),
        emptyLine(),
        new Paragraph({
          children: [new TextRun({ text: '--- END OF EXAMINATION PAPER ---', bold: true })],
          alignment: AlignmentType.CENTER,
          spacing: { before: 100, after: 100 },
        }),
      ],
    },
  ],
});

Packer.toBuffer(doc).then(buffer => {
  fs.writeFileSync('/home/daytona/workspace/exam-question/Preventive_Dentistry_Exam_NitrousOxide_50Marks.docx', buffer);
  console.log('Document created successfully!');
}).catch(err => {
  console.error('Error:', err);
  process.exit(1);
});